Patent & IP news for January 13, 2017

News from Abroad: Summary Report on the Final Guidance from the English Court of Appeal on Second Medical Use Patents from www.patentdocs.org

By David Brown* -- The final decision of the Court of Appeal in the Lyrica® litigation was handed down on 13 October 2016. This litigation, relating to the painkiller pregabalin marketed by Warner-Lambert for the treatment ...

Share via E–mail | Twitter | Facebook

ARIPO Lines Up IP Enhancing Activities For 2017 from www.ip-watch.org

CAPE TOWN, South Africa – From establishing training schemes, exchange expertise, sharing research, and helping members acquire and develop technology related to intellectual property and shape copyright associated rights, the African Regional Intellectual Property Organization (ARIPO ...

Share via E–mail | Twitter | Facebook

WEF Davos: Responsible Leadership, Fourth Industrial Revolution, Social Responsibility from www.ip-watch.org

Days away from the opening of the annual World Economic Forum in Davos, the founder of the forum described the main themes of the upcoming event, and underlined the role of social responsibility for business ...

Share via E–mail | Twitter | Facebook

WIPO Green Platform Expanding With Experts Database, Seeks Experts from www.ip-watch.org

The World Intellectual Property Organization internet platform WIPO GREEN is expanding by building a database of experts meant to help technology seekers find green technology specialists to provide their service and expertise.

Share via E–mail | Twitter | Facebook

Panels Present Importance Of Fair Use In South Africa’s Draft Copyright Amendment from www.ip-watch.org

CAPE TOWN, South Africa -- “Fair use” was at the heart of discussions between intellectual property stakeholders at a recent workshop called to discuss the revised draft copyright amendment bill of South Africa.

Share via E–mail | Twitter | Facebook

Step One of Alice Analysis Not Limited to Patent’s Novel Claims from docketreport.blogspot.com

The court denied defendants' motion to dismiss on the ground that plaintiff’s agrochemical spraying system patents encompassed unpatentable subject matter and rejected defendants' argument that the court must focus its analysis of step one ...

Share via E–mail | Twitter | Facebook

Estoppel Does Not Apply to Grounds Not Raised in Petition for Inter Partes Review from docketreport.blogspot.com

The court denied plaintiffs' motion to reconsider an earlier decision that defendant was not estopped from presenting a prior art combination at trial following inter partes review. "[M]y first look at the estoppel issue ...

Share via E–mail | Twitter | Facebook

Upcoming En Banc Argument from www.717madisonplace.com

The Federal Circuit will be sitting en banc in a non-patent case on February 7, 2017.  In Parkinson v. DOJ, the Federal Circuit will consider the following issue: Whether a preference eligible employee of the ...

Share via E–mail | Twitter | Facebook

Arrow declarations can be granted: Fujifilm v AbbVie from ipkitten.blogspot.com

The Court of Appeal decided yesterday that the High Court can, as a point of principle, properly grant declarations that a product lacked novelty or an inventive step at a particular date, see Fujifim Kyowa ...

Share via E–mail | Twitter | Facebook

Patent Quality: Where We Are from patentlyo.com

Guest Post by Professors Arti Rai (Duke) and Colleen Chien (Santa Clara).  Professors Rai and Chien both served in the Obama Administration.   On the eve of a new Administration, it is useful to take stock ...

Share via E–mail | Twitter | Facebook

Supreme Court Grants Cert in Amgen v. Sandoz & Sandoz v. Amgen from patentlyo.com

By Jason Rantanen Today, the Supreme Court granted certiorari in two dueling petitions involving the Federal Circuit’s 2015 interpretation of the Biologics Price Competition and Innovation Act of 2009.  Here are the questions presented ...

Share via E–mail | Twitter | Facebook

US Biotech Industry Head To India’s Modi: Follow Our IP Practices, Get ‘Tidal Wave’ Of Investment from www.ip-watch.org

US Biotechnology Innovation Organization CEO Jim Greenwood told Indian Prime Minister Narendra Modi this week if he follows western practices on intellectual property protection, his country would see a "tidal wave" of biotech industry investment.

Share via E–mail | Twitter | Facebook